54 articles, transcripts, and reports
Biogen Inc (BIIB) Q4 2019 earnings call dated Jan. 30, 2020 Corporate Participants: Joe Mara — Vice President, Investor Relations Michel Vounatsos — Chief Executive Officer Alfred Sandrock, Jr. — Executive…
— Biogen Inc. (NASDAQ: BIIB) reported its fourth-quarter 2019 adjusted earnings of $8.34 per share versus $8.02 per share expected. — Total revenues increased by…
Biogen Inc. (NASDAQ: BIIB) reported a 7% increase in earnings for the third quarter of 2019 as spinal muscular atrophy drug Spinraza and biosimilars drove…
The market value of pharma giant Biogen, Inc. (NASDAQ: BIIB) declined by a third in March when the stock suffered a heavy blow after the…
